Are Health Technology Assessments a reliable tool in the analysis of the clinical value of PET in oncology? Who audits the auditors? Liselotte Højgaard Editorial 12 April 2003 Pages: 637 - 641
A comparison of radionuclide thyroid angiography, 99mTc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules Koray DemirelÖzlem KapucuFerit Taneri Original Article 01 March 2003 Pages: 642 - 650
Peritumoural versus subareolar administration of technetium-99m nanocolloid for sentinel lymph node detection in breast cancer: preliminary results of a prospective intra-individual comparative study Sofiane MazaRay ValenciaDieter L. Munz Original Article 01 March 2003 Pages: 651 - 656
Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer Simon J. PainRobert W. BarberA. Michael Peters Original Article 22 March 2003 Pages: 657 - 661
99mTc-sestamibi uptake and histological malignancy grade in invasive breast carcinoma Rimma DanielssonAlejandro Sánchez-CrespoPeter Aspelin Original Article 04 March 2003 Pages: 662 - 666
A comparison of the biodistribution and biokinetics of 99mTc-anti-CD66 mAb BW 250/183 and 99mTc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy Inga BuchmannThomas KullSven N. Reske Original Article 22 February 2003 Pages: 667 - 673
Measuring [18F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods Nanda C. KrakJacobus J. M. van der HoevenAdriaan A. Lammertsma Original Article 15 March 2003 Pages: 674 - 681
[18F]FDG PET monitoring of tumour response to chemotherapy: does [18F]FDG uptake correlate with the viable tumour cell fraction? Karoline SpaepenSigrid StroobantsChristine De Wolf-Peeters Original Article 25 February 2003 Pages: 682 - 688
18F-DOPA positron emission tomography for the detection of glomus tumours Stefan HoegerleNadir GhanemHartmut P. H. Neumann Original Article 05 March 2003 Pages: 689 - 694
[18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression J. G. RajendranD. C. WilsonK. A. Krohn Original Article 11 March 2003 Pages: 695 - 704
The value of 18FDG-PET for the detection of infected hip prosthesis Benedicte VanquickenborneAlex MaesLuc Mortelmans Original Article 04 March 2003 Pages: 705 - 715
PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction H. G. BuchholzH. HerzogP. Bartenstein Short Communication 26 February 2003 Pages: 716 - 720
PET-CT: accuracy of PET and CT spatial registration of lung lesions Christian CohadeMedhat OsmanRichard L. Wahl Short Communication Pages: 721 - 726
Treatment of cultured glioma cells with the EGFR-TKI gefitinib ("Iressa", ZD1839) increases the uptake of astatinated EGF despite the absence of gefitinib-mediated growth inhibition Åsa Liljegren SundbergYlva AlmqvistJörgen Carlsson Short Communication 07 March 2003 Pages: 727 - 729
Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI J. MellerF. StrutzR. Vosshenrich Short Communication 04 April 2003 Pages: 730 - 736
Performance evaluation of the microPET R4 PET scanner for rodents Christof KnoessStefan SiegelWolf-Dieter Heiss Molecular Imaging Pages: 737 - 747
Tumour-specific activation of the sodium/iodide symporter gene under control of the glucose transporter gene 1 promoter (GTI-1.3) Stephanie SiegerShiming JiangUwe Haberkorn Molecular Imaging 23 January 2003 Pages: 748 - 756
Defining the success of cardiac gene therapy: how can nuclear imaging contribute? Norbert AvrilFrank M. Bengel Molecular Imaging 23 January 2003 Pages: 757 - 771
Therapeutic Applications of Monte Carlo Calculations in Nuclear Medicine Book reviews 08 May 2003 Pages: 772 - 772
Radioimmunotherapy: is avidin-biotin pretargeting the preferred choice among pretargeting methods? Giovanni PaganelliMarco Chinol Controversies—For 30 January 2003 Pages: 773 - 776
Radioimmunotherapy: Is avidin-biotin pretargeting the preferred choice among pretargeting methods? David M. GoldenbergChien-Hsing ChangJacques Barbet Controversies—Against 06 February 2003 Pages: 777 - 780
Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting Jean Claude ReubiBeatrice Waser Review Article 18 April 2003 Pages: 781 - 793
Should high hTg levels in the absence of iodine uptake be treated? K. E. BrittonR. R. FoleyS. L. Chew Letter to the Editor 04 March 2003 Pages: 794 - 795
99mTc-M-TRODAT is not superior to 99mTc-TRODAT-1 for the diagnosis of Parkinson's disease A. MaesH. VanbilloenA. Verbruggen Letter to the Editor 05 March 2003 Pages: 796 - 797
Interpretation of reverse redistribution of 99mTc-tetrofosmin in patients with acute myocardial infarction Theodoros AthanasoulisCherry A. Zervas Letter to the Editor 26 March 2003 Pages: 798 - 799
Molecular gastrin receptor localisation in mice using high-resolution SPET-MRI image fusion Tino SchurratHeiko AlfkeNils Schramm Image of the Month 26 March 2003 Pages: 800 - 800
Targeting cytokine/chemokine receptors: a challenge for molecular nuclear medicine A. Signore M. Chianelli A. Modesti Erratum Pages: 801 - 802
Guidelines for radioiodinated MIBG scintigraphy in children Pierre OlivierPaula ColarinhaJeannette van Velzen Blue Pages 26 March 2003 Pages: B45 - B50
Guidelines for direct radionuclide cystography in children Jure FettichPaula ColarinhaJeannette van Velzen Blue Pages 12 April 2003 Pages: B39 - B44